A national pilot program for chronic diseases and health inequalities in South Korea by Ha, Rangkyoung et al.
RESEARCH ARTICLE Open Access
A national pilot program for chronic
diseases and health inequalities in South
Korea
Rangkyoung Ha1, Dongjin Kim2, Jihee Choi2 and Kyunghee Jung-Choi3*
Abstract
Background: To achieve the health equity, it is important to reduce socioeconomic inequalities when managing
chronic diseases. In South Korea, a pilot program for chronic diseases was implemented at the national level. This
study aimed to examine its effect on socioeconomic inequalities in chronic disease management at the individual
and regional levels.
Methods: Korean National Health Insurance data from September 2016 to October 2017 were used. Study subjects
in the national pilot program for chronic diseases included 31,765 participants and 5,741,922 non-participants. The
dependent variable was continuity of prescription medication. Socioeconomic position indicators were health
insurance contribution level and the area deprivation index. Covariates were gender, age, and the Charlson
Comorbidity Index (CCI). A multilevel logistic regression model was used to address the effects at both the
individual and regional levels. This is a cross-sectional study.
Results: Unlike the group of non-participants, the participants showed no inequality in prescription medication
continuity according to individual-level socioeconomic position. However, continuity of prescription medication was
higher among those in less deprived areas compared to those in more deprived areas in both the participation and
non-participation groups.
Conclusions: This study found that the pilot program for chronic diseases at the least did not contribute to the
worsening of health inequalities at the individual level in South Korea. However, there was a trend showing health
inequalities based on the socioeconomic level of the area. These findings suggest that additional policy measures
are needed to attain equality in the management of chronic diseases regardless of the regional socioeconomic
position.
Keywords: Socioeconomic position, Area deprivation, Health inequality, Continuity of prescription medication,
Chronic disease management, Pilot program
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Background
Health ensures fair opportunities [1] and is an essential
element of human development [2]. Ethical value judg-
ments are involved in this meaning of health. Social in-
equalities in health are socially constituted by everyday
living conditions in which a person is born, grows, lives,
works and ages [3]. Thus, health inequalities are not
consistent with social justice [4] and are an important
issue that should be approached with fairness [5]. Al-
though efforts have been made to resolve such health in-
equalities in the world since the 2000s [3, 5, 6], these
inequalities have not been mitigated [7]. According to
the Marmot Review [5], the overall health of the UK
population has improved since 1995; however, disparities
in life expectancy at birth based on area and at the indi-
vidual level have worsened.
The situation in South Korea is similar. Life expect-
ancy at birth increased from 78.24 years in 2005 to
82.36 years in 2016 [8]; however, life expectancy at birth
differed depending on education and income level. In
2010, the life expectancy of people aged 30 with a mini-
mum of a college degree was 8.1 years higher than of
those who only graduated from middle school [9]. The
difference in life expectancy between high- and low-
income earners was 6.22 years among men and 1.74
years among women [10]. There were also regional dis-
parities in life expectancy with metropolitan areas having
relatively high life expectancies [9].
According to Korean researches, the prevalence of dia-
betes mellitus and hypertension also differed according
to socioeconomic position [11]. A lower prevalence was
found in those with higher education and income levels
[12–14]. According to a previous study, obesity, an
unhealthy diet and lack of physical activity were well-
known risk factors for chronic diseases, such as hyper-
tension or diabetes [15], and these conditions were more
common in people with low socioeconomic positions
[16]. Low socioeconomic levels may be associated with a
higher prevalence of diabetes or hypertension due to
limited access to information on health behavior and en-
vironmental exposures [17] or a lack of healthy foods
[18]. Socioeconomic position determines the distribution
of resources (e.g., power, income, and education), and
exposures (e.g., living conditions, working environment,
and community environment). The distribution of these
resources and exposure factors and the interaction be-
tween the two formulate material circumstances, health
behaviors, and psychosocial factors, which ultimately re-
sult in health inequalities [19]. People of a lower socio-
economic position were likely to experience housing
instability [20]. The social determinants of health were
also related to the incidence of diabetes [21, 22]. More-
over, a previous study reported poverty as a major con-
tributor to the increased prevalence of diabetes [23].
Health inequalities do not occur accidentally but are in-
fluenced by institutional, political, and economic con-
texts [19].
There were also inequalities in healthcare utilization
among patients with chronic diseases. Several studies
have found that income and education level affect
healthcare utilization [24, 25]. The Horizontal Inequity
Index (HI) adjusted for health needs indicated that high-
income patients used relatively more healthcare services
than low-income patients [24, 26].
In South Korea, as in any Western society, diabetes
and hypertension have become common diseases. The
prevalence of hypertension and diabetes increased
from 24.4 and 9.5% in 2007 to 29.1 and 11.3% in
2016, respectively, in people over 30 years of age [27].
Many pilot programs have attempted to effectively
manage the increasing number of patients with dia-
betes or hypertension, including a pilot program for
chronic diseases by the Ministry of Health and Wel-
fare (2016–2018). This program aimed to reduce the
incidence of diabetes and hypertension complications,
enhance self-management through non-face-to-face
management, and strengthen primary healthcare
through clinic use. When an outpatient visited a pri-
mary medical institution, a healthcare professional
would encourage him or her to participate in this
program. If they agreed, they were registered as a
program participant [28]. The main services included
establishing monthly patient chronic disease manage-
ment plans through face-to-face care and providing
feedback to patients after they sent blood pressure
and blood sugar level data to healthcare professionals
for analysis. In addition, this program provided con-
tinuous observation through non-face-to-face manage-
ment and phone consultations to encourage patients’
self-management skills if necessary. After monitoring,
the patient’s health was evaluated, and the results
were implemented into their care plan. Patients who
participated in this pilot program were exempt from
copayments [29].
Despite program implementation at the national level
for chronic diseases management, there are limited stud-
ies on whether it contributed to reducing health inequal-
ities. Previous studies have shown the effectiveness of
the pilot program for chronic diseases through evalu-
ation of patient satisfaction and self-monitoring of blood
pressure and blood glucose levels [30, 31]. However, to
our knowledge, there is an insufficient number of pub-
lished studies targeted at identifying whether the pilot
program for chronic diseases has helped mitigate health
inequalities. Therefore, we aimed to confirm whether
there are inequalities in participation and continuous
management of chronic diseases according to individual
and regional socioeconomic position. Our main objective
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was to identify whether there are inequalities in the pre-
scription medication continuity among non-participants
and participants of the pilot program with different so-
cioeconomic positions at the individual and regional
levels.
Methods
Data and study subjects
We used National Health Insurance data collected by
the National Health Insurance Service (NHIS) in South
Korea [32]. The National Health Insurance (NHI) is
compulsory and covers about 97% of the entire Korean
population [33]. The NHIS has maintained information
on those insured by NHI since 2002 and has constructed
the National Health Information Database (NHID) based
on this data. The NHID categories include eligibility,
health screening, healthcare utilization, and healthcare
provider database. The eligibility database includes resi-
dency, gender, age, income-based insurance contribu-
tion, and death records. The healthcare utilization
database comprises medical histories, including data on
procedures, surgeries, and treatment costs as well as in-
patient and outpatient prescription records. The health-
care provider database contains provider information,
types of providers available, number of providers, and
number of beds, as well as institutional data [34]. We
analyzed NHID customized data and used the informa-
tion regarding eligibility, healthcare utilization, and
healthcare provider. This study follows a cross sectional
design.
According to the International Classification of
Diseases version 10 (ICD-10) [35], hypertension code
I10–13 or diabetes mellitus code E10-E14 were se-
lected. We included outpatients who were prescribed
medication for hypertension or diabetes at least once
from outpatient clinics between September of 2016
and October of 2017. The total number of outpatients
with hypertension or diabetes was 6,358,623. Among
them, the patients who participated in the pilot pro-
gram for chronic diseases were labeled as participants,
and those who did not participate were labeled as
non-participants.
To confirm the pilot program’s effectiveness, 199, 690
outpatients living in regions where another pilot pro-
gram - the Community-Based Primary Care project -
was carried out, were excluded because the subjects of
this project were also outpatients with hypertension or
diabetes. The Community-Based Primary Care project
was implemented in only four regions: Jungnang-gu,
Seoul; Wonju, Gangwon-do; Jeonju-si, Jeollabuk-do;
and Muju-gun, Jeollabuk-do. Among these, we further
excluded 301,264 medical aid beneficiaries and 83,982
individuals with missing eligibility data. Our final
study subjects included 5,773,687 outpatients, com-
prising 31,765 participants and 5,741,922 non-
participants (Fig. 1).
Fig. 1 Flow chart of study subjects
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Study variables
We used prescription medication continuity as the
dependent variable because medication persistence is an
important factor in managing hypertension and diabetes
[36, 37]. Continuity of prescription medication was a di-
chotomous variable defined as prescription continuation
when the sum of the number of days on the prescription
was greater than or equal to the difference between the
prescription start date and the end date of data collec-
tion (October 30, 2017).
The explanatory variables consisted of socioeconomic
position: income-based insurance contribution and area
deprivation. As health insurance contributions in South
Korea are based on income, contribution level can be
used as a proxy of income level. Health insurance contri-
bution level is vigintile divided into 20 groups based on
the number of people insured [38]. We used the sample
data from the 2015 Population and Housing Census to
measure area deprivation in a South Korean context
[39]. The Population and Housing Census is a national
basic statistics survey conducted every 5 years to gather
data on the Korean population and houses. This survey
is for all Korean citizens and foreign nationals residing
in South Korea [40]. The area deprivation index in-
cluded the assessment of low social class, poor housing
conditions, low education level, no car ownership, di-
vorce or bereavement, one-person households, female
heads of household, the elderly population, and residents
not living in an apartment. The area deprivation index
was classified into quintiles, with Q1 being the most de-
prived and Q5 the least deprived.
Covariates were classified into demographic factors
and clinical characteristics. Demographic factors in-
cluded gender and age. Clinical characteristics consisted
of the Charlson Comorbidity Index (CCI), which was
originally developed to predict mortality [41], but has
been widely used as a severity-adjustment method [42].
CCI assigned a weighted score to 17 conditions classified
by ICD-10. Weighted scores ranged from 1 to 6, and the
sum of the weights is the Charlson score [43]. The
scores measured by CCI were divided into 0, 1, 2, and 3
points or more.
Statistical analysis
Descriptive analyses were carried out to identify general
characteristics. To confirm socioeconomic inequalities
based on participation in the pilot program, we calcu-
lated age-standardized participation rates according to
health insurance contribution levels and the area
deprivation index. We calculated age-standardized
continuity of prescription medication rates, and then
constructed a multilevel model for the hierarchical data
for both the participant and non-participant groups. A
multilevel model considering both the individual and
group levels can reflect within- and between-group vari-
ations [44]. We built an empty model (Model 0) that
included clinics as a random intercept. Next, we in-
cluded individual factors in Model 1 to investigate the
extent to which continuity of prescription medication
was explained by individual characteristics, such as gen-
der, age, and CCI. Finally, we built Model 2 by adding
Table 1 Characteristics of the study subjects
Variables Total Men Women
Totala Participantsb Total Participants Total Participants
Total 5,773,687 31,765 (0.55) 2,896,308 18,419 (0.64) 2,877,379 13,346 (0.46)
Age (years)
≤ 30 13,064 93 (0.71) 9133 65 (0.71) 3931 28 (0.71)
30–39 76,660 520 (0.68) 58,832 398 (0.68) 17,828 122 (0.68)
40–49 430,906 3530 (0.82) 311,354 2539 (0.82) 119,552 991 (0.83)
50–59 1,259,869 8501 (0.67) 750,889 5206 (0.69) 508,980 3295 (0.65)
60–69 1,759,402 9907 (0.56) 918,544 5726 (0.62) 840,858 4181 (0.50)
70–79 1,344,292 6804 (0.51) 566,579 3428 (0.61) 777,713 3376 (0.43)
80–89 756,931 2235 (0.30) 252,990 1016 (0.40) 503,941 1219 (0.24)
≥ 90 132,563 175 (0.13) 27,987 41 (0.15) 104,576 134 (0.13)
CCI
0 2,530,844 10,088 (0.40) 1,258,343 5650 (0.45) 1,272,501 4438 (0.35)
1 1,666,283 9849 (0.59) 840,740 5703 (0.68) 825,543 4146 (0.50)
2 878,687 6014 (0.68) 451,526 3627 (0.80) 427,161 2387 (0.56)
3+ 697,873 5814 (0.83) 345,699 3439 (0.99) 352,174 2375 (0.67)
aTotal study subjects in this study, bParticipants of the national pilot program for chronic diseases
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an area deprivation variable to address the effect at the
regional level.
We conducted a multilevel logistic regression analysis
using the SAS GLIMMIX procedure (PROC GLIMMIX,
SAS V9.4, SAS Institute, Cary, NC, USA).
Results
Table 1 shows the general characteristics of the study sub-
jects. Overall, 31,765 (0.55%) patients participated in the
pilot program for chronic diseases. There were 18,419
male participants (0.64%) and 13,346 female participants
(0.46%). The participation rate was the highest among
those aged 40–49 years (0.82%). Patients with higher CCI
scores were more likely to participate in the pilot program.
When the study population was divided by gender, a simi-
lar pattern was shown. The participation rate was high
among both males and females aged 40–49 years.
Figure 2 presents the age-standardized rates of partici-
pation and prescription medication continuity according
to socioeconomic position. There was no clear difference
in the age-standardized participation rates based on
health insurance contribution level or area deprivation.
The participation rates in the lowest and highest insur-
ance contribution vigintile were 0.58 and 0.51%, respect-
ively. The participation rate of patients in the most
deprived area and the least deprived were 0.66 and
0.56%, respectively. The number of participants tended
to be lower in the more deprived areas and among those
with lower health insurance contribution levels (Fig. 2A,
B). Regarding urbanization level, 18,900 (0.72%) partici-
pants resided in a metropolis, followed by participants
from rural areas 2536 (0.51%), and participants from
small-to-medium sized cities 10,329 (0.39%) (Supple-
mental Table 1).
The age-standardized continuity of prescription medi-
cation rate for all study subjects was 44.72%; 59.53% for
participants and 44.64% for non-participants (Supple-
mental Table 2). The rate improved approximately 15%
according to participation status. Among participants,
the rate did not show any trend based on insurance con-
tribution level. However, among non-participants, the
higher the insurance contribution level, the higher the
rate of prescription medication continuity (Fig. 2C). Ac-
cording to area deprivation, the rate of prescription
medication continuity among people living in less de-
prived areas tended to be higher compared with those
living in severely deprived areas. The rates in the least
and most deprived areas were 60.83 and 52.54%, respect-
ively. The difference between the two groups was 8.3%
points.
Fig. 2 Age-standardized rates of participation and continuity of prescription medication by health insurance contribution level and area
deprivation, Note: * The lowest (Q1) and the highest (Q20); † The most-deprived (Q1) and the least-deprived (Q5). A: The distribution of age-
standardized participation rates by health insurance contribution level. B: The distribution of age-standardized participation rates by area
deprivation index. C: Trend in age-standardized prescription medication continuity by health insurance contribution level and participation status
D: Trend in age-standardized prescription medication continuity by area deprivation index and participation status
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Table 2 shows the results of a multilevel logistic re-
gression for a non-participation group and participation
group, respectively. In the non-participation group, we
found an association between prescription medication
continuity and socioeconomic position. Continuity of
prescription medication was significantly associated with
insurance contribution level. This implied that patients
with higher income were likely to continue with pre-
scriptions. Also, the less deprived the area, the higher
likelihood of continuity of prescription medication. In
Model 2, women were more likely than men to continue
with their prescriptions (OR: 1.09, 95% CI: 1.08–1.09).
Older individuals had a higher likelihood of continuity
of prescription medication. Compared with patients with
a Charlson score of 0, those with a Charlson score of 1
or higher showed greater continuity of prescription
medication.
The association between continuity of prescription
medication and socioeconomic position of the participa-
tion group is also shown in Table 2. There was no statis-
tically significant likelihood of continuing prescriptions
based on health insurance contribution. However, as the
degree of deprivation decreased, prescription medication
continuity increased. In addition, continuity of prescrip-
tion medications differed according to gender and age.
Discussion
We studied the effect of prescription medication con-
tinuity according to the pilot program for chronic dis-
eases considering socioeconomic position. We found no
inequality in participation, and that in the participation
group, there was no inequality in continuity of
prescription medication according to individual-level so-
cioeconomic position. In both the participation and
non-participation group, there were inequalities in pre-
scription medication continuity in terms of area-level so-
cioeconomic position.
The age-standardized participation rate was 0.55%
and showed no trend based on health insurance con-
tribution level or area deprivation. While encouraging
that the participation rate did not differ according to
socioeconomic position, a low participation rate
makes it difficult to conclude that there was no in-
equality in participation rates.
The age-standardized prescription medication con-
tinuity rates increased by approximately 15% when
people participated in the pilot program for chronic dis-
eases. This suggests that the pilot program was effective.
The main purpose of this program was to focus on man-
aging diabetes and hypertension through continuous
monitoring. Patients’ blood pressure and blood sugar
levels were checked more than once a week, and the re-
sults were sent to the clinics. A healthcare professional
provided feedback via text messages. If necessary, a tele-
phone consultation including recommended medication
or lifestyle changes would be conducted [29]. These ser-
vices may encourage the continued use of prescriptions.
Several studies found that programs assisting patients
with uncontrolled hypertension (i.e., blood pressure
levels ≥140/90 mmHg) helped lower the level of blood
pressure control. These programs taught patients how to
measure blood pressure at home, and helped them im-
prove their medication adherence and lifestyle [45–47].
Also, patients who received regular blood pressure
Table 2 Association between continuity of prescription medication and socioeconomic characteristics in non-participants and
participants (Odds Ratio (95% Confidence Interval))
Non-participants Participants
Variables Model 1 Model 2 Model 1 Model 2
Individual level
Gender
Men 1 1 1 1
Women 1.09 (1.08–1.09) 1.09 (1.08–1.09) 1.11 (1.06–1.16) 1.11 (1.06–1.16)
Age 1.01 (1.01–1.02) 1.01 (1.01–1.02) 1.02 (1.02–1.03) 1.02 (1.02–1.03)
CCI
0 1 1 1 1
1 1.08 (1.08–1.09) 1.08 (1.08–1.09) 0.94 (0.88–1.02) 0.95 (0.88–1.02)
2 1.10 (1.10–1.11) 1.10 (1.10–1.11) 0.99 (0.93–1.07) 0.99 (0.93–1.07)
3+ 1.08 (1.08–1.09) 1.08 (1.08–1.09) 0.99 (0.93–1.05) 0.99 (0.93–1.05)
Health insurance contribution level 1.04 (1.04–1.05) 1.04 (1.04–1.05) 0.99 (0.99–1.00) 0.99 (0.99–1.00)
Regional level
Area deprivation 1.07 (1.07–1.08) 1.08 (1.03–1.12)
Model 1: gender, age, CCI, and health insurance contribution level, Model 2: Model 1 + the area deprivation index
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telemonitoring interventions had better adherence to
anti-hypertensive medication than patients receiving
standard care [48].
According to a qualitative analysis of the pilot program
for chronic diseases in Korea [30], participants were
more likely recognize themselves as healthcare subjects
and took responsibility for their health. They realized
the importance of managing their lifestyle at home and
work while monitoring changes in blood pressure and
blood glucose level. These changes could also have posi-
tive effects on the health of participants. A previous
study identified that education programs solely focused
on drug adherence, physical exercise, or smoking cessa-
tion for self-management did not improve long-term
glycemic control [49]. Patients with hypertension and
diabetic complications who participated in the Patient
Empowerment Programme (PEP) showed better clinical
metabolic control outcomes than non-PEP patients [50].
Patient empowerment can be defined as the process of
becoming autonomous through enhancing one’s ability
to think critically and make informed decisions when al-
tering behavior [51]. Patients should be internally moti-
vated to manage their health, not dependent on external
factors [52]. Thus, it would be preferable if the pilot pro-
gram for chronic diseases provided services to educate
patients on hypertension and diabetes, review test re-
sults, and develop skills in program-solving, goal setting,
coping, and stress management [53].
Regarding socioeconomic position at the individual
level, our findings showed that the pilot program did not
worsen health inequality within the participation group.
Non-participants with higher health insurance contribu-
tion levels had greater continuity with prescriptions
compared to those with lower levels. However, there is
no significant association between continuity of prescrip-
tion medication and health insurance contribution level
in the participation group. This pilot program was
exempted from patient copayments. In 2018, partici-
pants received an average of 24 USD per month [54], a
financial incentive designed to help people who need to
visit clinics regularly. A study examining the financial
burden of healthcare services for low-income individuals
in Korea reported that people in the lowest-income
quintile spent six times more on out-of-pocket payments
than those in the highest-income quintile, because the
lowest level had a higher prevalence of chronic disease
[55]. People with high-income used more prescription
medications and spent more money on prescriptions,
while reporting less financial burden from prescription
medications [56] than people with a low income. A pre-
vious study found that medication adherence appeared
to decrease with increasing patient copayments among
individuals in low-income areas [57]. Out-of-pocket pay-
ments could interfere with access to prescription
medication and lead to the discontinuation of medica-
tion [58]. Therefore, low-income patients may be more
reliant on financial aid.
In addition, patients who participated in the pilot pro-
gram could receive phone consultations to support life-
style improvements, and doctors evaluated their health
status through monitoring. One advantage of this pilot
program was providing consultations on risk factors.
There is a knowledge gap between people of different
socioeconomic positions based on information flow [59].
People from low-socioeconomic groups had less expos-
ure to information on preventing chronic diseases [60]
and less awareness of the causes of diseases, which could
lead to health disparities [61]. In the light of previous re-
search, the information provided in the pilot program
could help manage chronic diseases among patients of a
low-socioeconomic status.
Patients living in less deprived areas were more likely
to have continuity of prescription medication in both
the participation and non-participation groups, which
implies that there could be health inequalities based on
area deprivation regardless of participation status. A pre-
vious study identified that medication adherence was
lower among patients in low-income areas compared to
those in high-income areas [57]. Health disparities be-
tween areas were identified using compositional and
contextual effects [62]. Our finding showed that there
were still discrepancies in prescription medication con-
tinuity between areas after adjusting for individual char-
acteristics. Several studies have reported that the
socioeconomic position of a region influenced health
disparities between individuals [63–67]. Social and phys-
ical features in one neighborhood may affect individual
health or access to opportunities for healthy living [62].
Unequal distribution of socioeconomic resources at
the regional level is one of the important mechanisms
leading social inequalities. There are fewer resources
such as good schools or parks in disadvantaged neigh-
borhoods [68]. Residents in poorer areas may have fewer
job opportunities as well [69]. Similarly, inequalities in
the distribution of healthcare resources may lead to dif-
ferences in medication adherence. A study investigating
the distribution of healthcare resources by classifying re-
gional economic levels based on local tax per person in
Korea reported that healthcare resources including the
number of specialists, pharmacists, clinics, and pharma-
cies were advantageously distributed in richer areas [70].
Patients in poorer areas tended to receive less primary
healthcare than patients in richer areas [71]. In addition
to a quantitative shortage of resources, there may be a
lack of quality resources (i.e., health facilities, personnel,
and equipment) to meet the needs of people in deprived
areas [72]. Further research on the association between
the distribution of regional healthcare resources and
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medication adherence based on socioeconomic position
in Korea is needed.
Our study has some limitations. First, we could not
consider the educational level and health behaviors re-
lated to chronic diseases [73–76] because the National
Health Insurance data does not include this information.
Second, patients who participated in the pilot program
for chronic diseases may be more motivated to manage
their health [50]. The degree of effect may have been
greater in the pilot program. However, it is difficult to
conclude that such an effect made a difference according
to the socioeconomic position. Third, distribution of re-
gional healthcare resources was not considered. How-
ever, clinics were included as random effects to adjust
for variation. Despite these limitations, our study used
National Health Insurance data that covered most of the
Korean population. To our knowledge, this study was
the first to identify whether the pilot program for
chronic diseases contributed to reducing health inequal-
ities based on the socioeconomic position at the individ-
ual and regional levels.
Conclusions
There was no difference in the program participation
rate at the individual or regional socioeconomic levels in
this pilot program. Our findings suggested that the pilot
program at the least did not worsen health inequalities
at the individual-level socioeconomic position. There
was, however, a trend showing health inequalities based
on the area-level socioeconomic position. The actual ef-
fect of policy intervention may vary depending on socio-
economic position. Therefore, it is necessary to consider
the equity perspective in the management of chronic
diseases.
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